SNDL(NASDAQ) SNDL

Current Price$1.29

Market Cap$333.18M

Since IPO (2019)-98%

5 Year-85%

1 Year-17%

1 Month-10%

SNDL last closing stock price
Metric	Price	Date
Last close	USD 1.28	2026-07-20

SNDL stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-2.29%	USD 1.31	2026-07-13
1 month	-9.86%	USD 1.42	2026-06-18
3 month	-15.23%	USD 1.51	2026-04-21
Year to date	-22.89%	USD 1.66	2025-12-31
1 year	-16.88%	USD 1.54	2025-07-18
3 year	-7.91%	USD 1.39	2023-07-21
5 year	-85.29%	USD 8.70	2021-07-21
Since inception	-98.49%	USD 84.80	2019-08-01

SNDL Financials at a Glance

Market Cap

$333.18M

Revenue (TTM)

CA$937.39M

Net Income (TTM)

-CA$10.98M

EPS (TTM)

-$0.03

P/E Ratio

-40.51

Dividend

$0.00

Beta (Volatility)

1.40 (Average)

Dividend

$0.00

Beta (Volatility)

1.40 (Average)

Price

$1.29

Volume

551,636

Open

$1.28

Price

$1.29

Volume

551,636

Open

$1.28

Previous Close

$1.29

Daily Range

$1.27 - $1.29

52-Week Range

$1.26 - $2.89

Estimated Earnings Date

Jul 28, 2026

Dividend

$0.00

Beta (Volatility)

1.40 (Average)

Price

$1.29

Volume

551,636

Open

$1.28

Previous Close

$1.29

Daily Range

$1.27 - $1.29

52-Week Range

$1.26 - $2.89

Estimated Earnings Date

Jul 28, 2026

SNDL News

SNDL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SNDL

SNDL Inc. is a Canadian company focused on the cultivation, distribution, and sale of cannabis products. The firm operates through two segments: Cannabis Operations and Retail Operations, catering to the adult-use market with a variety of cannabis products.

Products and Services

Offers a range of inhalable cannabis products, including dried flower and vape cartridges
Operates corporate-owned and franchised retail outlets for direct cannabis sales
Markets products under key brands like Top Leaf and Sundial Cannabis

Growth Outlook

Recent quarterly revenue reached CAD 195.9 million, indicating strong market demand
Cash and cash equivalents stood at CAD 233.4 million, providing financial stability
Operating cash flow of CAD 3.5 million demonstrates operational efficiency

Financial Highlights

Trailing twelve months (TTM) revenue of CAD 1.0 billion reflects consistent growth
Current ratio of 4.84 indicates strong liquidity position
Net income for Q4 2025 was CAD 9.4 million, showcasing profitability

SNDL Inc. has positioned itself as a significant player in the cannabis industry, with a diverse product offering and a robust retail network. The company's financial metrics indicate a solid foundation, with a strong liquidity position and recent profitability. The growth outlook remains positive, supported by increasing revenue and operational efficiency. Investors may find SNDL Inc. an intriguing opportunity within the evolving cannabis market.

AI Generated • Jul 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,751

CEO

Zachary Ryan George

Website

www.sndl.com

Headquarters

Calgary, AB T2R 1P3, CA

SNDL Financials

Key Financial Metrics (TTM)

Gross Margin

27.18%

Operating Margin

-0.79%

Net Income Margin

-1.17%

Return on Equity

-1.00%

Return on Capital

-0.35%

Return on Assets

-0.84%

Earnings Yield

-2.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$333.18M

Shares Outstanding

260.30M

Volume

551.64K

Avg. Volume

2.35M

Financials (TTM)

Gross Profit

CA$254.82M

Operating Income

-CA$7.42M

EBITDA

CA$49.42M

Operating Cash Flow

CA$66.61M

Capital Expenditure

-CA$13.86M

Free Cash Flow

CA$52.75M

Cash & ST Invst.

CA$233.86M

Total Debt

CA$168.25M

SNDL Performance Analysis

SNDL annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	CAD 547,063,864	1122.0%
2023	2023-12-31	CAD 673,493,946	23.1%
2024	2024-12-31	CAD 671,878,695	-0.2%
2025	2025-12-31	CAD 677,312,492	0.8%

SNDL sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	19.4%
Q3	2025-09-30	-0.2%
Q4	2025-12-31	3.4%
Q1	2026-03-31	-22.4%

SNDL annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	CAD -1.12	15.1%
2023	2023-12-31	CAD -0.49	-56.5%
2024	2024-12-31	CAD -0.26	-46.2%
2025	2025-12-31	CAD -0.04	-83.3%

SNDL sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	119.1%
Q3	2025-09-30	-584.8%
Q4	2025-12-31	148.7%
Q1	2026-03-31	-249.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CA$195.91M

-4.4%

Gross Profit

CA$52.81M

-6.8%

Gross Margin

26.96%

N/A

Market Cap

$333.18M

N/A

Market Cap/Employee

$121.11K

N/A

Employees

2,751

N/A

Net Income

-CA$9.91M

+32.6%

EBITDA

CA$2.71M

+106.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

CA$233.86M

+4.2%

Total Debt

CA$168.25M

+13.7%

Accounts Receivable

CA$31.91M

+7.2%

Inventory

CA$137.85M

+1.4%

Long Term Debt

CA$133.29M

+16.2%

Short Term Debt

CA$34.97M

+5.1%

Return on Assets

-0.84%

N/A

Return on Invested Capital

-0.60%

N/A

Free Cash Flow

CA$843.00K

-86.4%

Operating Cash Flow

CA$3.48M

-55.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ORGOOrganogenesis Holdings Inc.

ORGOOrganogenesis Holdings Inc.$2.68+1.90%

AKBAAkebia Therapeutics, Inc.

AKBAAkebia Therapeutics, Inc.$1.30+1.56%

EOLSEvolus, Inc.

EOLSEvolus, Inc.$5.81+4.69%

EBSEmergent BioSolutions Inc.

EBSEmergent BioSolutions Inc.$7.65-0.52%

AQSTAquestive Therapeutics, Inc.

AQSTAquestive Therapeutics, Inc.$4.04+2.41%

SIGASIGA Technologies, Inc.

SIGASIGA Technologies, Inc.$3.58+2.87%

ESPREsperion Therapeutics, Inc.

ESPREsperion Therapeutics, Inc.$3.18+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$7.66+0.11%

PATHUiPath

PATHUiPath$12.04-0.01%

TAT&T

TAT&T$22.26+0.01%

NOKNokia

NOKNokia$10.63+0.05%

MARAMara Holdings

MARAMara Holdings$12.25+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.28+0.01%

JOBYJoby Aviation

JOBYJoby Aviation$7.66+0.03%

Questions About SNDL

What is the current price of SNDL?

SNDL is trading at $1.29 per share.

What is the 52-week range for SNDL?

Over the past 52 weeks, SNDL has traded between $1.26 and $2.89.

How much debt does SNDL have?

As of the most recent reporting period, SNDL reported total debt of CA$120.65M.

How much cash does SNDL have on hand?

SNDL reported CA$167.34M in cash and cash equivalents in its most recent financial results.

What is SNDL’s dividend yield?

SNDL does not currently have a dividend yield.

SNDL(NASDAQ) SNDL

SNDL Financials at a Glance

SNDL News

Best Cannabis ETFs to Buy in 2026 and How to Invest

3 Reasons Why SNDL Might Be the Best Cannabis Stock of 2024 and 2025

SNDL Will Soon Pass a Big Milestone, But Is the Stock a Buy?

These Cannabis 3 Stocks Are Set to Soar This Summer and Beyond

Is SNDL Stock a Buy?

Here's How SNDL Stock Could Fly for the Rest of 2024 and Beyond

SNDL Stock Is Up 35% This Year. Here's Why It'll Go Higher.

Is SNDL Stock a Buy?

SNDL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About SNDL

SNDL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

SNDL Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SNDL

What is the current price of SNDL?

What is the 52-week range for SNDL?

How much debt does SNDL have?

How much cash does SNDL have on hand?

What is SNDL’s dividend yield?

Premium Investing Services